Plastrum Testudinis Extracts Promote NSC Differentiation into Dopaminergic Neuron by Regulating the Interaction of TET1 and FoxA2

In recent years, stem cells have gained much attention for the treatment of neurodegenerative diseases. However, inducing neural stem cell directionally differentiation is a difficult problem in the treatment of Parkinson's disease (PD) by stem cell therapy. Plastrum Testudinis (PT) can enhance the number of TH-positive neurons in the PD rat brain substantia nigra, but the underlying mechanism has not been clarified. Here, we aimed at further investigating the mechanism by which PT can promote NSC differentiation into dopaminergic neurons. A rat model of PD was used for detecting the effect of PT on the rat brain substantia nigra in vivo. The results showed the expressions of tyrosine hydroxylase (TH) and TET1 enzyme were increased after treatment with PT. Consequently, Plastrum Testudinis extracts (PTEs) were used for inducing NSC differentiation into dopaminergic neurons ex vivo. During differentiation of NSCs induced by PTE, TH expression was increased, with a concomitant increase in both TET1 and FoxA2. Next, we performed coimmunoprecipitation analysis to examine the interaction between TET1 protein and FoxA2 protein. Our results show that PTE can increase the binding rate of TET1 and FoxA2. Thus, our findings show that PTE can increase the efficiency of NSCs to directionally differentiate into dopaminergic neurons and provide experimental evidence for PT in the treatment of Parkinson's disease.

[1]  Li‐yan Li,et al.  Transplantation of Nurr1‐overexpressing neural stem cells and microglia for treating parkinsonian rats , 2019, CNS neuroscience & therapeutics.

[2]  Q. Shang,et al.  Effect of Plastrum Testudinis Extracts on the Proliferation and Osteogenic Differentiation of rBMSCs by Regulating p38 MAPK-Related Genes , 2019, Evidence-based complementary and alternative medicine : eCAM.

[3]  Bin Wang,et al.  Epigenetic Regulations in Neural Stem Cells and Neurological Diseases , 2018, Stem cells international.

[4]  Q. Shu,et al.  The Dynamic DNA Demethylation during Postnatal Neuronal Development and Neural Stem Cell Differentiation , 2018, Stem cells international.

[5]  Chuanshan Xu,et al.  The Effect of Traditional Chinese Medicine on Neural Stem Cell Proliferation and Differentiation , 2017, Aging and disease.

[6]  Zhaohui S. Qin,et al.  Ten-eleven translocation 2 interacts with forkhead box O3 and regulates adult neurogenesis , 2017, Nature Communications.

[7]  Z. Herceg,et al.  TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors , 2017, Stem cell reports.

[8]  Yi Zhang,et al.  TET-mediated active DNA demethylation: mechanism, function and beyond , 2017, Nature Reviews Genetics.

[9]  G. Kempermann,et al.  Resveratrol Enhances Neuroplastic Changes, Including Hippocampal Neurogenesis, and Memory in Balb/C Mice at Six Months of Age , 2015, PloS one.

[10]  Ping Zhong,et al.  Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons , 2015, Nature Communications.

[11]  Alison I. Bernstein,et al.  5-Hydroxymethylcytosine: A new player in brain disorders? , 2015, Experimental Neurology.

[12]  K. Ross,et al.  The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine , 2015, Nature Cell Biology.

[13]  Mirang Kim,et al.  Vitamin C Facilitates Dopamine Neuron Differentiation in Fetal Midbrain Through TET1‐ and JMJD3‐Dependent Epigenetic Control Manner , 2015, Stem cells.

[14]  Parinya Noisa,et al.  Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases. , 2015, World journal of stem cells.

[15]  J. You,et al.  Epigenetic activation of the Foxa2 gene is required for maintaining the potential of neural precursor cells to differentiate into dopaminergic neurons after expansion. , 2015, Stem cells and development.

[16]  L. Rong,et al.  Effects of Salvia miltiorrhiza on neural differentiation of induced pluripotent stem cells. , 2014, Journal of ethnopharmacology.

[17]  K. Kaestner,et al.  Foxa1 and Foxa2 Are Required for the Maintenance of Dopaminergic Properties in Ventral Midbrain Neurons at Late Embryonic Stages , 2013, The Journal of Neuroscience.

[18]  T. Dall,et al.  The current and projected economic burden of Parkinson's disease in the United States , 2013, Movement disorders : official journal of the Movement Disorder Society.

[19]  J. Jui,et al.  Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. , 2013, Cell reports.

[20]  Dong-feng Chen,et al.  Chemical Components in Extracts from Plastrum Testudinis with Proliferation‐Promoting Effects on Rat Mesenchymal Stem Cells , 2012, Chemical biology & drug design.

[21]  G. Mercanti,et al.  A 6-hydroxydopamine in vivo model of Parkinson's disease. , 2012, Methods in molecular biology.

[22]  S. Daubner,et al.  Tyrosine hydroxylase and regulation of dopamine synthesis. , 2011, Archives of biochemistry and biophysics.

[23]  Riitta Lahesmaa,et al.  Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. , 2011, Cell stem cell.

[24]  K. Kaestner,et al.  Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development. , 2009, Developmental biology.

[25]  R. Barker,et al.  Cell replacement therapy for Parkinson's disease. , 2009, Biochimica et biophysica acta.

[26]  Sohail Ahmed,et al.  The culture of neural stem cells , 2009, Journal of cellular biochemistry.

[27]  S. Ang,et al.  Foxa1 and Foxa2 transcription factors regulate differentiation of midbrain dopaminergic neurons. , 2009, Advances in experimental medicine and biology.

[28]  A. Albanese,et al.  Levodopa-induced dyskinesias and their management , 2008, Journal of Neurology.

[29]  J. Whitsett,et al.  Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner , 2007, Development.

[30]  Hui Li,et al.  Extracts from plastrum testudinis promote proliferation of rat bone‐marrow‐derived mesenchymal stem cells , 2007, Cell proliferation.

[31]  F. Gage,et al.  Mammalian neural stem cells. , 2000, Science.

[32]  M. Murer,et al.  Levodopa in Parkinson’s Disease , 1999, Drug safety.